Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC

Published:2016-12 Issue:1 Volume:594 Page:23-29
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Yin Hanlu,Wang Yi,Chen Wenping,Zhong Shanliang,Liu Zhian,Zhao Jianhua

Funder

Natural Science Foundation of Jiangsu Province

Key Research Program for the Social Development of Jiangsu Province

Medical Science and Technology Development Foundation

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference32 articles.

1. Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers;Alves;Front. Biosci. (Landmark Ed),2009

2. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay;Baccelli;Nat. Biotechnol.,2013

3. Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells;Bertran;Hepatology,2013

4. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data;Cerami;Cancer Discov.,2012

5. A perspective on cancer cell metastasis;Chaffer;Science,2011

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression;Cancer Cell International;2023-10-08

2. A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma;Aging;2022-12-01

3. CXCR4 expression is associated with proneural‐to‐mesenchymal transition in glioblastoma;International Journal of Cancer;2022-10-31

4. Prognostic significance of SPARC expression in non‑small cell lung cancer: A meta‑analysis and bioinformatics analysis;Oncology Letters;2022-09-27

5. Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer;Cancers;2022-09-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3